Qube Research & Technologies LTD Abeona Therapeutics Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 161,880 shares of ABEO stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161,880
Previous 60,681
166.77%
Holding current value
$1.13 Million
Previous $383,000
134.46%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABEO
# of Institutions
69Shares Held
28.7MCall Options Held
631KPut Options Held
2.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$27.3 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$25.8 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$24.7 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.12MShares$14.8 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$14.6 Million7.9% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $41.7M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...